Gout

Genetic variants associated with both an increased and decreased likelihood of developing gout have been discovered by researchers from the Icelandic genomics company deCODE along with academic colleagues in Iceland, Norway, Denmark, the Netherlands, and the United States.

The latest clinical research into the causes and treatment of gout.

The price to buy Colchicine is going through the roof, causing much concern from the hundreds of thousands of people taking the medication each year.

A new study has shown that MRI can identify and describe the features of gout.

Research has found that the prevalence of hyperuricemia and gout in adult patients with sickle cell disease in France was not a clinical problem..

Many researchers are blaming the national obesity epidemic for causing a growing number of Americans contracting gout, a painful form of arthritis.

Gout Diet - There is no reason for individuals who either have gout or are at risk of developing gout to avoid soyfoods.

Use of pegloticase resulted in lower uric acid levels compared with placebo in patients with chronic gout.

Recombinant uricases provide an exciting new therapeutic option for gout, but there are limited data for their use in the elderly.

The latest in clinical news for the detection and treatment of gout.

The latest clinical research on the detection and treatment of gout.

Serum uric acid control in gout was poor among patients without chronic kidney disease (CKD) and even worse among those with CKD.

The latest clinical research into the causes and treatments for gout.

A new study shows the prevalence of gout in the US has risen over the last 20 years and now affects 8.3 million (4%) Americans.

The latest in clinical research into gout and related disorders.

An update on the latest clinical research in gout.

The latest clinical research into gout.

Until Uloric became available last year we didn't have much else we could use to prevent attacks of recurrent gout in patients who could not take allopurinol.

Colchicine toxicity was frequent in a small cohort of hospitalized patients and may have contributed to several deaths.

The Food and Drug Administration has deemed canakinumab unsafe for consumers, despite its effectiveness for treating acute flares of gout.

A new treatment for treating Gout can normalize levels of uric acid in the blood within hours in patients who have failed to respond to any other treatments.

Watch this video for a brief discussion of options for the medical management of gout pain.

Prior to an FDA ban on unapproved colchicine products, the drugs cost $0.10 a pill. The only FDA-approved colchicine product costs $5 a pill.

Learn about findings from recent studies of gout, crystalline arthritis, and hyperuricemia.

A podcast dedicated to those suffering from gout, hosted by Victor Konshin, author of, "Beating Gout: A Sufferer's Guide to Living Pain Free."

As seen on the Discovery Health series Body Invaders, learn how gout arthritis can affect the human body.

80-90% of gout patients under-excrete uric acid while the major therapeutic options treat over-production of uric acid.

Two studies highlight the challenges to effective treatment posed by hypertension, diabetes, and other comorbid conditions in patients with gout.

Gout sufferers with high levels of uric acid may increase risk of developing severe osteoarthritis.

Michael Kottgen and Owen Woodward discuss their discovery of a urate transporter, ABCG2, which may play a role in gout.